As you remember the first time we tested the 1:1 ratio of : CBD in Cannatonic (a strain I created for Resin Seeds) was also during a Spannabis fair, the 2009 edition, when we gave a sample to be analyzed by CANNA laboratories. From that moment on I have been working with Shantibaba on CBD since we were both genuinely interested in bringing this powerful molecule to patients. During the past dec
Show more ...As you remember the first time we tested the 1:1 ratio of : CBD in Cannatonic (a strain I created for Resin Seeds) was also during a Spannabis fair, the 2009 edition, when we gave a sample to be analyzed by CANNA laboratories. From that moment on I have been working with Shantibaba on CBD since we were both genuinely interested in bringing this powerful molecule to patients. During the past decade science has demonstrated that CBD is a potent antioxidant with strong anti-inflammatory qualities. Shanti and I both believe that patients should be given a chance to cultivate and employ CBDrich cannabis to self-medicate. We wish to offer a well tested natural alternative in a seed form. Cannabidiol —CBD— is a compound in Cannabis that offers various beneficial properties. Taken alone, CBD is not psychoactive; when mixed with it tends to smooth and modulate the euphoric effects of , often this is something patients tend to dislike in high strains. After decades only high- Cannabis, CBD-rich strains are now being grown by and for medical patients. CBD has demonstrated neuro-protective effects in some pathological conditions, and its anti-cancer potential is currently being explored at several academic research centers worldwide (try to search “CBD cancer Guzman” on google for more insights). The reduced psychoactivity of CBD-rich cannabis makes it an appealing treatment option for patients seeking anti-pain, anti-anxiety, anti-inflammatory and/or anti-spasm effects without some of the typical effects of , like euphoria. Many scientific and clinical studies indicate that CBD could be effective in easing symptoms of a wide range of difficult-to-control conditions, including:rheumatoid arthritis, diabetes, alcoholism, PTSD, epilepsy, antibiotic-resistant infections and neurological disorders. Each test grower will receive 10 seeds of a new CBD-rich cross – our goal is for many growers in different climates to grow out 10 seeds and analyze a sample of each plant so ultimately we can verify that we reached our goal of offering 100% CBD-rich seeds to patients.